PATENT CLAIM ANALYSIS

Application Number: 15981598
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["435", "060000"]

Abstract:
The present application relates to novel substituted 5-fluoro-1H-pyrazolopyridines, to processes for their preparation, to their use alone or in combinations for the treatment and/or prophylaxis of diseases, and to their use for producing medicaments for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of cardiovascular disorders.

Claim (Index 33):
The method of  claim 18 , wherein the method further comprises administering a further active compound that is an agent having blood pressure lowering activity selected from the group consisting of losartan, candesartan, valsartan, telmisartan, embusartan, bosentan, darusentan, ambrisentan, sitaxsentan, and spironolactone and eplerenone.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 93.0
- Lexical Diversity: 1.80645
- Patent Class: 435.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15348545', '13111856', '14552122', '14194224', '13882118']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6702808681036144
- 35 USC 102 Novelty (BERT): 0.5569958728259726
- Combined Prediction Score: 0.6589523685758503
- Mean Citation Score: 380.31979400000006
- Max Citation Score: 433.06305
- Similarity Product: 347.50333986265366

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test